As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.

The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry.  It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.

Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities.  Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.